Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium
- PMID: 34217424
- PMCID: PMC8241650
- DOI: 10.1016/j.ypmed.2021.106540
Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium
Abstract
The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%) reported closing or operating at reduced capacity at some point during this period. All facilities were open by August 2020, though 14% were still operating at reduced capacity in September 2020. During periods of re-opening or reduced capacity, 93% of facilities reported prioritizing diagnostic breast imaging over breast cancer screening. For diagnostic imaging, facilities prioritized based on rescheduling canceled appointments (89%), specific indication for diagnostic imaging (89%), patient demand (84%), individual characteristics and risk factors (77%), and time since last imaging examination (72%). For screening mammography, facilities prioritized based on rescheduled cancelations (96%), patient demand (83%), individual characteristics and risk factors (73%), and time since last mammogram (71%). For biopsy services, more than 90% of facilities reported prioritization based on rescheduling of canceled exams, patient demand, patient characteristics and risk factors and level of suspicion on imaging. The observed patterns from this large and geographically diverse sample of facilities in the United States indicate that multiple factors were commonly used to prioritize breast imaging services during periods of reduced capacity.
Keywords: Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening.
Copyright © 2021 Elsevier Inc. All rights reserved.
Figures
Comment in
-
COVID-19 and the disruption of cancer screening programs: Key lessons for the recovery.Prev Med. 2021 Oct;151:106687. doi: 10.1016/j.ypmed.2021.106687. Epub 2021 Jun 30. Prev Med. 2021. PMID: 34217408 Free PMC article. No abstract available.
References
-
- Ballard-Barbash R., Taplin S.H., Yankaskas B.C., Ernster V.L., Rosenberg R.D., Carney P.A., Barlow W.E., Geller B.M., Kerlikowske K., et al. Breast Cancer surveillance Consortium: a national mammography screening and outcomes database. AJR Am. J. Roentgenol. 1997;169:1001–1008. - PubMed
-
- Breast Cancer Surveillance Consortium Breast Cancer Surveillance Consortium: Working Together to Advance Breast Cancer Research. 2021. http://www.bcsc-research.org Accessed January 22, 2021.
-
- Centers for Disease Control and Prevention CDC COVID Data Tracker. 2021. https://covid.cdc.gov/covid-data-tracker/#cases_casesper100k Accessed January 22, 2021.
-
- EPIC Health Research Network Delayed Cancer Screenings – A Second Look. 2020. https://ehrn.org/articles/delayed-cancer-screenings-a-second-look Accessed November 2, 2020.
